Physician profile
Hamed Khosravi
NPI 1407802671
$16,175.05
in general payments reported to CMS, 2019-2025
80 companies · $2,639 in 2025
The $2,639 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,507 · 2020: $595 · 2021: $1,253 · 2022: $1,772 · 2023: $6,268 · 2024: $2,142 · 2025: $2,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,514 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,975 · Travel and Lodging: $998 · Long Term Medical Supply Or Device Loan: $299 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,513.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,975.00 |
| Travel and Lodging | $997.98 |
| Long Term Medical Supply Or Device Loan | $299.10 |
| Education | $262.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $3,325.86 | 2019-2025 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $1,656.70 | 2019-2025 | |
| Janssen Biotech, INC. | $1,302.60 | 2019-2025 | Tecvayli, Erleada, Darzalex |
| Pfizer INC. | $656.41 | 2019-2025 | |
| Emd Serono, INC. | $580.68 | 2019-2023 | Tepmetko |
| Merck Sharp & Dohme LLC | $514.86 | 2019-2025 | Keytruda, Lynparza |
| Genentech USA, INC. | $467.22 | 2019-2025 | Tecentriq, Venclexta, Polivy |
| Abbvie INC. | $455.55 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $436.19 | 2019-2025 | Enhertu, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $384.10 | 2019-2025 | Opdivo, Eliquis |
| Daiichi Sankyo INC. | $366.76 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Eisai INC. | $332.62 | 2019-2025 | |
| Amgen INC. | $309.88 | 2019-2024 | Kyprolis, Lumakras, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $294.19 | 2019-2025 | Ninlaro, Iclusig |
| Horizon Therapeutics Plc | $223.51 | 2019-2023 | Krystexxa, Tepezza |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $217.99 | 2020-2024 | Pomalyst |
| Beigene USA, INC. | $213.22 | 2020-2025 | Brukinsa |
| Incyte Corporation | $212.53 | 2020-2025 | Jakafi, Monjuvi, Pemazyre |
| Pharmacyclics LLC, An Abbvie Company | $201.91 | 2019-2023 | Imbruvica |
| Astellas Pharma US INC | $191.58 | 2020-2025 | Xtandi, Xospata, Padcev |
| Kite Pharma, INC. | $187.64 | 2020-2023 | Yescarta |
| Genzyme Corporation | $181.90 | 2019-2025 | |
| Servier Pharmaceuticals LLC | $175.46 | 2022-2025 | |
| Gilead Sciences, INC. | $170.75 | 2019-2025 | Trodelvy |
| Coherus Oncology, INC. | $168.47 | 2022-2025 | Udenyca, Loqtorzi |
| Spectrum Pharmaceuticals INC. | $156.65 | 2023-2025 | Rolvedon |
| Myriad Genetic Laboratories, INC. | $134.29 | 2022-2025 | Myrisk |
| Array Biopharma INC | $132.18 | 2021-2025 | Lorbrena, Braftovi, Mektovi |
| Regeneron Healthcare Solutions, INC. | $131.38 | 2023-2025 | Libtayo |
| Lilly USA, LLC | $124.68 | 2019-2023 | Verzenio, Retevmo, Jaypirca |
| Alexion Pharmaceuticals, INC. | $108.95 | 2019-2024 | Ultomiris |
| Pharmacosmos Therapeutics INC. | $105.10 | 2023-2025 | Monoferric |
| Clovis Oncology, INC. | $101.00 | 2019-2020 | |
| Mirati Therapeutics, INC. | $94.54 | 2023 | Krazati |
| Taiho Oncology, INC. | $87.82 | 2023 | |
| Tg Therapeutics, INC. | $87.68 | 2022 | |
| Genmab U.S., INC. | $85.99 | 2023-2024 | Epkinly |
| Puma Biotechnology, INC. | $85.87 | 2020-2025 | |
| Sobi, INC | $84.49 | 2025 | |
| Dendreon Pharmaceuticals LLC | $79.24 | 2019-2025 | Provenge |
| Adaptive Biotechnologies Corporation | $77.44 | 2022-2025 | Clonoseq |
| Pharmaessentia USA Corporation | $67.71 | 2023 | Besremi |
| Sumitomo Pharma America, INC. | $64.66 | 2024 | Orgovyx |
| G1 Therapeutics, INC. | $63.36 | 2022-2023 | Cosela |
| Ipsen Biopharmaceuticals, INC | $58.66 | 2023-2024 | Somatuline Depot, Onivyde, Tazverik |
| Amneal Pharmaceuticals LLC | $58.60 | 2023-2025 | Alymsys, Avastin |
| Janssen Pharmaceuticals, INC | $50.80 | 2020-2023 | Xarelto |
| Glaxosmithkline, LLC. | $47.67 | 2022-2024 | Ojjaara |
| Tersera Therapeutics LLC | $47.38 | 2024-2025 | Quzyttir |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.78 | 2019-2024 | |
| Rigel Pharmaceuticals, INC. | $45.48 | 2020-2023 | Rezlidhia, Tavalisse |
| Seagen INC. | $44.53 | 2021-2022 | |
| Sirtex Medical INC | $43.58 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.58 | 2021-2023 | |
| Lundbeck LLC | $38.86 | 2021-2022 | |
| Deciphera Pharmaceuticals INC. | $38.53 | 2021-2023 | Qinlock |
| Partner Therapeutics, INC. | $36.18 | 2019 | |
| Alnylam Pharmaceuticals INC. | $35.25 | 2023-2025 | Givlaari |
| Stemline Therapeutics INC. | $28.61 | 2023 | Orserdu |
| Azurity Pharmaceuticals, INC. | $24.81 | 2025 | Danziten |
| Pharmaand Gmbh | $24.70 | 2025 | Rubraca |
| Tolmar, INC. | $24.70 | 2025 | Rubraca, Eligard |
| Accord Healthcare, INC. | $23.62 | 2025 | |
| Celltrion USA INC. | $23.20 | 2024 | Vegzelma |
| Boston Scientific Corporation | $23.01 | 2019 | |
| Tempus Ai, INC | $21.83 | 2025 | Xt Cdx |
| Beone Medicines USA, INC. | $21.67 | 2025 | Brukinsa, Tevimbra |
| Novocure INC. | $21.19 | 2025 | Optune Lua (Novottf-200t) |
| Morphosys, US INC. | $21.11 | 2023 | Monjuvi |
| Blueprint Medicines Corporation | $20.12 | 2022 | |
| Sandoz INC. | $20.11 | 2025 | Zarxio |
| Foundation Medicine, INC. | $17.44 | 2023 | |
| Medtronic, INC. | $17.10 | 2023 | Intellis Adaptivestim |
| Zydus Pharmaceuticals (USA) INC. | $16.90 | 2025 | |
| Amag Pharmaceuticals, INC. | $16.29 | 2019 | |
| Heron Therapeutics, INC. | $15.56 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.67 | 2019 | |
| Cti Biopharma Corp. | $14.34 | 2023 | Vonjo |
| Secura Bio, INC. | $13.96 | 2019 | |
| Adc Therapeutics America, INC. | $13.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamed Khosravi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.